AAR Corp., a leading independent value-added aftermarket solution provider, has reported outstanding results for its third ...
Absci, a leader in the field of artificial intelligence (AI)-powered biotechnology, has reported strong financial and operating results for its fourth quarter and full year ended December 31, 2025.
Spectral AI, a leading developer of innovative diagnostic tools, has released its 2025 fourth quarter and full year financial results, showcasing remarkable progress towards commercializing its ...
Fractyl Health, a pioneer in the field of obesity treatment, has made significant strides in Q4 2025, leaving investors and analysts alike excited about the company's prospects. In a recent conference ...
MaxCyte, a leading biotechnology company, has made significant strides in a year marked by operational headwinds. Despite the ...
In a stellar performance, Blaize Holdings, Inc. has announced its fourth quarter 2025 earnings call, highlighting a remarkable year of growth and success. The company's CEO, Dinakar Munagala, took the ...
Home, a leading homebuilder in the United States, announced impressive first-quarter 2026 earnings, showcasing its ...
Paysign, a leading player in the patient affordability space, has just reported its fourth quarter and full year financial ...
Smithfield Foods, the leading American meat processor and packaged meats company, has announced its outstanding financial ...
Kolibri Global Energy Inc., a leading energy company, has made headlines with its outstanding Q4 2025 financial results. The ...
BioCardia, a leader in cardiovascular disease treatment, recently reported its Q4 2025 results, marking a significant milestone in the company's mission to develop and enhance therapies for this ...
LENZ Therapeutics has made significant strides in its launch of LNZ100, a once-daily eye drop designed to address presbyopia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results